KRT19 and breast carcinoma: Interestingly, CK19 expression is the most common single marker used for the RT-PCR-based detection of DTCs in the BM of breast cancer patients, and the detection of DTCs expressing this particular cytokeratin is correlated to an unfavorable prognosis because of metastatic relapse [6].